Status:

RECRUITING

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Lead Sponsor:

University of Michigan

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Diabetic Foot Ulcer

Diabetic Foot

Eligibility:

All Genders

18+ years

Brief Summary

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be ...

Detailed Description

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be ...

Eligibility Criteria

Inclusion

  • Provision of signed and dated informed consent form.
  • Age 18 years or older.
  • Clinically diagnosed with diabetes or meeting the American Diabetes Association (ADA) criteria. \[ADA Standards of Clinical Care Diabetes Care 2022, Suppl 1\]
  • Open foot ulcer, defined as an open wound from malleolus down. This includes post-surgical wounds within this area left open to heal by secondary intention. In case of multiple ulcers, the largest ulcer will be considered the study index DFU.
  • Agreement to adhere to protocol visits and provide all required biospecimens and clinical data.

Exclusion

  • Participation in an interventional clinical trial for DFU within 1 month of Visit 1.
  • Currently receiving radiation to target area or chemotherapy.
  • Gangrene in any portion of the foot with the index ulcer.
  • Planned revascularization or under evaluation for revascularization of the index limb for advanced ischemia within next 4 weeks of Week 0.
  • Severe limb ischemia (SVS WIfl Ischemia grade 3).
  • Any concomitant medical or psychiatric condition that, in the opinion of the investigator(s), would compromise the participant's ability to safely complete the study.

Key Trial Info

Start Date :

June 15 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 15 2028

Estimated Enrollment :

5000 Patients enrolled

Trial Details

Trial ID

NCT06104969

Start Date

June 15 2023

End Date

June 15 2028

Last Update

September 15 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

University of Arizona College of Medicine

Tucson, Arizona, United States, 85724

2

University of Southern California

Los Angeles, California, United States, 90033

3

University of California - San Francisco

San Francisco, California, United States, 94143

4

Emory University School of Medicine

Atlanta, Georgia, United States, 30303

DFC 004 Biomarkers for Active Diabetic Foot Ulcers | DecenTrialz